… There are currently some differences in the research results of molnupiravir. This study
aimed to evaluate the efficacy and safety of molnupiravir in the treatment of COVID-19. …

… Authorization in three countries for the treatment of mild COVID-19. The aim of this systematic
review was to find out the safety and efficacy of Molnupiravir in SARS-COV-2 infections. …

… Our analysis does not support routine use of molnupiravir for COVID-19 treatment in …
outpatients with risk factors treated with molnupiravir. Moreover, safety concerns have been raised …

… meta-analysis to increase the statistical power of the available evidence by combining it
and evaluating the safety and efficacy of molnupiravir for the treatment of COVID-19 patients. …

… that molnupiravir was effective in treating COVID-19 caused by Omicron variant infection,
with few adverse effects. Compared to basic treatment, molnupiravir treatment significantly …

… Therefore, molnupiravir still plays a key role in the treatment of … demonstrated that early
molnupiravir treatment is effective in … efficacy of molnupiravir in treating patients with COVID-19. …

… We conducted a retrospective cohort study that included all people treated with molnupiravir
between January 10, 2022, and March 31, 2022, at the University Hospital of Sassari. …

… , is being repurposed for the treatment of COVID-19. This study evaluates the efficacy
and safety of molnupiravir in addition to the standard-of-care (SOC) for the treatment of non-…

… Molnupiravir has been shown to be effective in preventing … In this study, we evaluate the
efficacy and safety of molnupiravir … ratio to receive molnupiravir in addition to SoC treatment (n = …

… This study aimed to determine which oral antiviral treatment (nirmatrelvir/ritonavir or
molnupiravir) is more effective in improving clinical outcomes in patients with COVID-19. A growing …